San Diego, CA 8/21/18; Washington, DC 8/22/18—Life science instrument firm Bionano Genomics has completed an IPO, listing on the NASDAQ (see IBO 7/31/18). The company offered 3,360,000 units (each unit consists of one share and a warrant to purchase one share) at a price of $6.125 per unit, generating gross proceeds of $20.6 million before underwriting and offering expenses. On September 21, the common stock and warrants will begin trading separately under the respective symbols BNGO and BNGOW, respectively.

Before expenses, the company announced proceeds of $19.1 million. The company had initially planned to offer 3.35 million shares at a price of $8–$10 per share. The stock closed out the month at a price of $6.20 per share.